Skip to content

    DiaMedica Therapeutics (DMAC) stock price & financials

    View DMAC earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+6.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    Operating Profit
    -$6.88M
    -$8.42M
    -$8.14M
    -$8.01M
    -$9.03M
    -31.2%
    -$9.21M
    -9.4%
    -$10.48M
    -28.7%
    -$10.50M
    -31.1%
    Weakening
    Net Profit
    -$6.27M
    -$7.90M
    -$7.71M
    -$7.70M
    -$8.62M
    -37.4%
    -$8.74M
    -10.6%
    -$10.04M
    -30.3%
    -$10.14M
    -31.7%
    Weakening
    EPS
    $-0.15
    $-0.18
    $-0.18
    $-0.17
    -13.3%
    $-0.19
    -5.6%
    $-0.19
    -5.6%
    Weakening
    Other Income
    $616.0K
    $314.0K
    $419.0K
    -32.0%
    Interest
    Depreciation
    Profit before Tax
    -$6.27M
    -$7.89M
    -$7.70M
    -$7.69M
    -$8.61M
    -37.5%
    -$8.73M
    -10.6%
    -$10.04M
    -30.3%
    -$10.13M
    -31.7%
    Weakening
    MarginsOPM
    Tax
    -0.1%
    -0.1%
    -0.1%
    -0.1%
    -0.1%
    +36.4%
    -0.1%
    +0.0%
    -0.1%
    +12.5%
    -0.1%
    +12.5%
    Strengthening
    ReturnsROIC
    2.7%
    3.4%
    3.3%
    3.3%
    3.7%
    +37.4%
    3.8%
    +10.6%
    4.3%
    +30.3%
    4.4%
    +31.7%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$16.82M$3.88M$7.41M$4.71M$4.73M$4.54M$3.02M$15.65M$5.13M
    Short-Term Investments$4.00M$20.10M$40.41M$28.77M$48.35M$41.12M$44.24M$38.38M
    Total Current Assets$17.97M$8.84M$27.92M$45.44M$33.84M$53.67M$44.61M$60.63M$44.31M
    Net PP&E$96.0K$217.0K$174.0K$112.0K$560.0K$485.0K$427.0K$342.0K$286.0K
    Goodwill
    Intangibles
    Total Assets$18.34M$9.05M$28.09M$45.55M$34.40M$54.16M$46.34M$61.37M$45.00M
    LiabilitiesTotal Current Liabilities$1.30M$1.32M$2.03M$1.52M$2.17M$2.79M$5.39M$5.13M$6.59M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$105.0K$46.0K$3.0K$396.0K$316.0K$225.0K$124.0K$69.0K
    Total Liabilities$1.31M$1.44M$2.08M$1.53M$2.57M$3.10M$5.63M$5.26M$6.66M
    EquityCommon Stock & APIC$0$0$0$0$0$0$0
    Retained Earnings-$45.97M-$56.62M-$68.91M-$82.50M-$96.18M-$115.56M-$140.00M-$172.77M-$192.95M
    Total Equity$17.02M$7.62M$26.01M$44.02M$31.83M$51.06M$40.72M$56.11M$38.34M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$5.70M-$9.10M-$9.19M-$12.25M-$11.51M-$18.73M-$22.08M-$29.06M-$31.51M
    Cash from Investing-$50.0K-$3.91M-$16.13M-$20.54M$11.54M-$18.30M$8.56M-$2.19M-$11.64M
    Cash from Financing$21.22M$70.0K$28.84M$30.09M-$6.0K$36.84M$11.99M$43.88M$44.17M
    SummaryCapital Expenditure-$50.0K-$2.0K-$47.0K-$22.0K-$81.0K-$24.0K-$25.0K-$40.0K-$33.0K
    Free Cash Flow-$5.75M-$9.10M-$9.23M-$12.27M-$11.59M-$18.75M-$22.10M-$29.10M-$31.54M
    FCF Margin-1149.2%

    Ratios